5-OMe-UDP is a Potent and Selective P2Y(6)-receptor Agonist
Overview
Authors
Affiliations
P2Y nucleotide receptors (P2Y-Rs) play important physiological roles. However, most of the P2Y-R subtypes are still lacking potent and selective agonists and antagonists. Based on data mining analysis of binding interactions in 44 protein-uridine nucleos(t)ides complexes, we designed uracil nucleotides, substituted at the C5/C6 position. All C6-substituted derivatives were inactive at the P2Y(2,4,6)-Rs, while out of the C5-substituted analogues, only 5-OMe-UD(T)P showed activity. To rationalize the data, the ionization and conformation of these analogues were evaluated. The pK(a) values of most analogues substituted at the C5/C6 positions were unaltered compared to UTP (pK(a) 9.42), except for 5-F-UTP nucleotide (pK(a) 7.85). C6-substituted analogues adopt the syn or high-syn conformations, which are disfavored by the receptors, while 5-OMe-UD(T)P adopt the favored anti conformation. Furthermore, 5-OMe-UDP adopts the S sugar puckering, which is the conformation preferred by the P2Y(6)-R, but not the P2Y(2)- or P2Y(4)-Rs. 5-OMe-UDP fulfills the conformational and H-bonding requirements of P2Y(6)-R, thus, making a potent P2Y(6)-R agonist (EC(50) 0.08 microM), more than UDP (EC(50) 0.14 microM).
Machine learning-aided search for ligands of P2Y and other P2Y receptors.
Puhl A, Lewicki S, Gao Z, Pramanik A, Makarov V, Ekins S Purinergic Signal. 2024; 20(6):617-627.
PMID: 38526670 PMC: 11554998. DOI: 10.1007/s11302-024-10003-4.
Pharmacological characterization of P2Y receptor subtypes - an update.
von Kugelgen I Purinergic Signal. 2023; 20(2):99-108.
PMID: 37697211 PMC: 10997570. DOI: 10.1007/s11302-023-09963-w.
Oliva P, Scortichini M, Dobelmann C, Jain S, Gopinatth V, Toti K Bioorg Med Chem Lett. 2021; 45:128137.
PMID: 34048882 PMC: 8276771. DOI: 10.1016/j.bmcl.2021.128137.
Endo K, Sakamoto A, Fujisawa K Sci Rep. 2021; 11(1):6989.
PMID: 33772064 PMC: 7997929. DOI: 10.1038/s41598-021-86433-6.
Machon C, Catez F, Dalla Venezia N, Vanhalle F, Guyot L, Vincent A J Pharm Anal. 2021; 11(1):77-87.
PMID: 33717614 PMC: 7930635. DOI: 10.1016/j.jpha.2020.04.001.